Research Article
Evaluation of Idiopathic Choroidal Neovascularization with Indocyanine Green Angiography in Patients Undergoing Bevacizumab Therapy
Table 1
The baseline means and distributions of the study population.
| | Variable | Outcome |
| | Age (years) | 38.7 (±10.0) |
| | Gender | Female: 19 (55.8%) | | Male: 15 (44.1%) |
| | Best-corrected visual acuity (logMAR) | 0.52 (±0.20) |
| | Central macular thickness on optical coherence tomography (microns) | 355.8 (±38.3) |
| | Choroidal neovascularization surface on indocyanine green angiography (mm2) | 1.82 (±1.69) |
| | Choroidal neovascularization surface on fluorescein angiography (mm2) | 2.36 (±1.91) |
|
|
